← Назад

Dermatitis herpetiformis

ORPHA:1656DiseaseNot applicableAll ages

Фенотипы (26)

Очень частый (80–99%)11
HP:0000989Pruritus
HP:0001025Urticaria
HP:0001935Microcytic anemia
HP:0002024Malabsorption
HP:0002757Recurrent fractures
HP:0002960Autoimmunity
HP:0008066Abnormal blistering of the skin
HP:0010783Erythema
HP:0012538Gluten intolerance
HP:0012733Macule
HP:0200037Skin vesicle
Частый (30–79%)7
HP:0000964Eczematoid dermatitis
HP:0033565Anti-epidermal transglutaminase antibody positivity
HP:0033637Anti-endomysial antibody positivity
HP:4000026Anti-transglutaminase 6 antibody
HP:4000029Antigliadin antibody positivity
HP:4000030Anti-reticulin antibody positivity
HP:4000031Anti-type VII collagen antibody
Периодический (5–29%)6
HP:0000684Delayed eruption of teeth
HP:0000820Abnormality of the thyroid gland
HP:0000969Edema
HP:0002653Bone pain
HP:0009722Dental enamel pits
HP:0100725Lichenification
Очень редкий (1–4%)2
HP:0000707Abnormality of the nervous system
HP:0031446Erosion of oral mucosa

Эпидемиология (11)

Point prevalence
1-5 / 10 000
Europe
Annual incidence
1-9 / 1 000 000
Italy
Annual incidence
1-9 / 100 000
Ireland
Point prevalence
1-5 / 10 000
Ireland
Annual incidence
1-9 / 100 000
Sweden
Point prevalence
1-5 / 10 000
Sweden
Annual incidence
1-9 / 1 000 000
United States
Point prevalence
1-5 / 10 000
United States
Annual incidence
1-9 / 100 000
Finland
Point prevalence
6-9 / 10 000
Finland
Point prevalence
1-5 / 10 000
United Kingdom

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы